Quark Pharmaceuticals

OverviewSuggest Edit

Quark Pharmaceuticals, Inc., the world leader in novel therapeutic RNAi discovery and development, has the largest clinical-stage siRNA pipeline in the industry. The Company’s fully integrated drug development platform spans therapeutic target identification to drug development. Quark’s approach to delivery allows targeting of tissues and organs including the eye, kidney, ear, lung, skin, spinal cord and brain. Quark has three siRNA product candidates in clinical development in five different disease indications of which two are in pivotal Phase III studies. Quark’s Joint Venture in China, Kunshan Ribo-Quark Pharmaceutical Inc, and its strategic partner in India, Biocon Limited, are part of Quark’s worldwide clinical studies network. Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel.
HQNewark, CA, US

Latest Updates

Employees (est.) (May 2018)78(-1%)
Cybersecurity ratingAMore

Key People/Management at Quark Pharmaceuticals

Daniel Zurr

Daniel Zurr

President and CEO
Rami Skaliter

Rami Skaliter

Shai Erlich

Shai Erlich

Chief Development Officer
Show more

Quark Pharmaceuticals Office Locations

Quark Pharmaceuticals has an office in Newark
Newark, CA, US (HQ)
7999 Gateway Blvd #310
Show all (1)

Quark Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date


Quark Pharmaceuticals total Funding

$37 m

Quark Pharmaceuticals latest funding size

$10 m

Time since last funding

11 years ago

Quark Pharmaceuticals investors

Quark Pharmaceuticals's latest funding round in June 2010 was reported to be $10 m. In total, Quark Pharmaceuticals has raised $37 m
Show all financial metrics

Quark Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Quark Pharmaceuticals Online and Social Media Presence

Embed Graph

Quark Pharmaceuticals Blogs

Quark Pharmaceuticals Announces Acceptance of Presentation and Abstracts at ASN 2018 (October 23-28, 2018) and AAO 2018 (October 27-30, 2018) Annual Meetings

FREMONT, Calif., Oct. 22, 2018 — Quark Pharmaceuticals, Inc., a late clinical-stage pharmaceutical company and leader in the discovery and development of novel RNAi-based therapeutics for unmet medical needs, today announced the acceptance of several abstracts on two major products, teprasiran (prev…

Quark Pharmaceuticals Frequently Asked Questions

  • When was Quark Pharmaceuticals founded?

    Quark Pharmaceuticals was founded in 1994.

  • Who are Quark Pharmaceuticals key executives?

    Quark Pharmaceuticals's key executives are Daniel Zurr, Rami Skaliter and Shai Erlich.

  • How many employees does Quark Pharmaceuticals have?

    Quark Pharmaceuticals has 78 employees.

  • Who are Quark Pharmaceuticals competitors?

    Competitors of Quark Pharmaceuticals include Avacta Group, Patterson Veterinary Supply and Actinium Pharmaceuticals.

  • Where is Quark Pharmaceuticals headquarters?

    Quark Pharmaceuticals headquarters is located at 7999 Gateway Blvd #310, Newark.

  • Where are Quark Pharmaceuticals offices?

    Quark Pharmaceuticals has an office in Newark.

  • How many offices does Quark Pharmaceuticals have?

    Quark Pharmaceuticals has 1 office.